Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors

Area of Science:

• Vascular biology
• Oncology
• Molecular signaling

Background:

• Tyrosine phosphorylation plays a critical role in cellular signaling pathways.
• Tumor vasculature exhibits unique characteristics compared to normal vasculature.
• Understanding vascular responses in tumors is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the role of tyrosine phosphorylation in modulating vascular responses of mesenteric arteries supplying colorectal tumors.
• To compare the effects of tyrosine phosphorylation on vascular tone in tumoral versus control arteries.

Main Methods:

• Isometric tension recording in an organ bath to measure arterial contraction and relaxation.
• Administration of sodium orthovanadate to modulate tyrosine phosphorylation levels.
• Analysis of protein expression for Vascular Endothelial Growth Factor A (VEGF-A) and its receptors (FLT1, KDR).

Main Results:

• Increased tyrosine phosphorylation led to arterial contraction, which was significantly lower in tumoral arteries compared to control arteries.
• Tyrosine phosphorylation reduced noradrenaline-induced contraction in tumoral arteries but not in control arteries.
• Tyrosine phosphorylation reduced bradykinin-induced relaxation in control arteries but not in tumoral arteries.
• Expression of VEGF receptor KDR was elevated in tumoral arteries.

Conclusions:

• Tyrosine phosphorylation appears to inhibit contraction in tumoral mesenteric arteries.
• This inhibitory effect may contribute to increased blood flow to the tumor.
• VEGF receptor signaling, particularly KDR, may be involved in mediating these vascular responses in tumors.